Your browser doesn't support javascript.
loading
Safety and efficacy of adding sitagliptin to insulin in patients with type 2 diabetes: the ASSIST-K study.
Takai, Masahiko; Ishikawa, Masashi; Maeda, Hajime; Kanamori, Akira; Kubota, Akira; Amemiya, Hikaru; Iizuka, Takashi; Iemitsu, Kotaro; Iwasaki, Tomoyuki; Uehara, Goro; Umezawa, Shinichi; Obana, Mitsuo; Kaneshige, Hideaki; Kaneshiro, Mizuki; Kawata, Takehiro; Sasai, Nobuo; Saito, Tatsuya; Takuma, Tetsuo; Takeda, Hiroshi; Tanaka, Keiji; Tsurui, Nobuaki; Nakajima, Shigeru; Hoshino, Kazuhiko; Honda, Shin; Machimura, Hideo; Matoba, Kiyokazu; Minagawa, Fuyuki; Minami, Nobuaki; Miyairi, Yukiko; Mokubo, Atsuko; Motomiya, Tetsuya; Waseda, Manabu; Miyakawa, Masaaki; Naka, Yoshikazu; Terauchi, Yasuo; Tanaka, Yasushi; Matsuba, Ikuro.
Afiliación
  • Takai M; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Ishikawa M; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Maeda H; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Kanamori A; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Kubota A; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Amemiya H; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Iizuka T; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Iemitsu K; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Iwasaki T; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Uehara G; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Umezawa S; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Obana M; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Kaneshige H; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Kaneshiro M; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Kawata T; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Sasai N; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Saito T; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Takuma T; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Takeda H; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Tanaka K; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Tsurui N; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Nakajima S; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Hoshino K; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Honda S; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Machimura H; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Matoba K; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Minagawa F; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Minami N; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Miyairi Y; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Mokubo A; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Motomiya T; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Waseda M; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Miyakawa M; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Naka Y; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan.
  • Terauchi Y; Department of Endocrinology and Metabolism, Yokohama City University, Kanagawa, Japan.
  • Tanaka Y; Department of Internal Medicine, Division of Metabolism and Endocrinology, St. Marianna University School of Medicine, Kanagawa, Japan.
  • Matsuba I; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan. Electronic address: ikuro@matsuba-web.com.
Diabetes Res Clin Pract ; 103(3): e30-3, 2014 Mar.
Article en En | MEDLINE | ID: mdl-24525293
ABSTRACT
We retrospectively studied more than 1000 patients with type 2 diabetes attending 36 Japanese clinics to investigate the efficacy and safety of adding sitagliptin to various insulin regimens. We found that the treatment with add-on sitagliptin for 6-months was effective, irrespective of the type or dose of concomitant insulin.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazinas / Triazoles / Diabetes Mellitus Tipo 2 / Hipoglucemiantes / Insulina Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Res Clin Pract Asunto de la revista: ENDOCRINOLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Japón Pais de publicación: IE / IRELAND / IRLANDA
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazinas / Triazoles / Diabetes Mellitus Tipo 2 / Hipoglucemiantes / Insulina Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Res Clin Pract Asunto de la revista: ENDOCRINOLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Japón Pais de publicación: IE / IRELAND / IRLANDA